Med costs, insurance worry New Yorkers, survey shows

The 2016 Empire State Healthcare Survey, conducted by the Cornell Institute for Healthy Futures, revealed that the cost of medical care and health insurance has many New Yorkers worried.

Scangos: Powerful medicine, not profit, is top biotech priority

George Scangos '70, CEO of Biogen, one of the most valuable biotech companies in the country, discussed balancing the needs of Wall Street and patients during his lecture as the Robert S. Hatfield Fellow in Economic Education.

Admissions underway for first class on new Cornell Tech campus

In August 2017, Cornell Tech's inaugural Roosevelt Island class will move into a campus built for innovation and creative collisions. Cornell Tech is accepting applications in seven master’s programs.

New model suggests scrubbing CO2 from the atmosphere

New Cornell research suggests an economically viable model to scrub carbon dioxide from the atmosphere to thwart runaway, point-of-no-return global warming.

National labor board, in its 81st year, adapts to the times

National Labor Relations Board Chairman Mark Pearce '75 spoke on "Change and Challenges: The NLRB after 81 Years" at Cornell Law School Oct. 24.

Cornell leads effort to train farmers on new produce safety rules

Cornell is leading a national alliance aimed at improving the safety of fresh produce and helping fruit and vegetable growers meet new regulatory requirements of the Food Safety Modernization Act.

'NutriPhone' startup joins Cornell's McGovern incubator

Put healthful eating in the palm of your hand: VitaMe Technologies – the Cornell start-up group that makes NutriPhone for personal nutrition testing – has joined the university's McGovern Center incubator.

Coalition taps private sector to help nature pay for itself

Cornell has co-founded a global coalition to help preserve the world's most important ecosystems. The coalition will create new opportunities for private investment in conservation and sustainable development.

Hatfield talk takes on challenges of drug discovery Oct. 27

George Scangos '70 will discuss how innovative biopharmaceutical companies are developing transformative therapies and working to ensure patients' access to them while meeting the demands of shareholders.